PAG
UTHR icon

Private Advisor Group’s United Therapeutics UTHR Stock Holding History

Private Advisor Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Buy
1,388
+498
+56% +$280K ﹤0.01% 1526
2026
Q1 		$528K Buy
890
+15
+2% +$7.47K ﹤0.01% 1819
2025
Q4 		$426K Buy
+875
New +$407K ﹤0.01% 1927
2023
Q4 		– Sell
-107
Closed -$24.2K – 2510
2023
Q3 		$24.2K Buy
+107
New +$24.6K ﹤0.01% 2092

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Private Advisor Group's UTHR Position: Q2 2026 in Review

Private Advisor Group increased its United Therapeutics (UTHR) stake by 56% in Q2 2026, buying an estimated $280K and bringing the position to 1,388 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Private Advisor Group first reported a position in UTHR in Q3 2023 and has held it in 4 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Private Advisor Group held 1,388 shares of United Therapeutics worth $752K as of Q2 2026.
  • Private Advisor Group bought 498 United Therapeutics shares in Q2 2026, an estimated $280K.
  • United Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1526 holding.
  • Private Advisor Group first reported a position in United Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.